Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Anticoagulation-associated upper gastrointestinal haemorrhage.

Bell S, Nand J, Dawes M.

Intern Med J. 2013 Aug;43(8):952. doi: 10.1111/imj.12217. No abstract available.

PMID:
23919341
2.

A comparison of results of the US food and drug administration's mini-sentinel program with randomized clinical trials: the case of gastrointestinal tract bleeding with dabigatran.

Sipahi I, Celik S, Tozun N.

JAMA Intern Med. 2014 Jan;174(1):150-1. doi: 10.1001/jamainternmed.2013.12217. No abstract available.

PMID:
24247291
3.

Dabigatran and postmarketing reports of bleeding.

Southworth MR, Reichman ME, Unger EF.

N Engl J Med. 2013 Apr 4;368(14):1272-4. doi: 10.1056/NEJMp1302834. Epub 2013 Mar 13. No abstract available.

4.

Meta-analysis should not be subject to selectivity and imbalance.

Lewis LS.

BMJ. 2015 Jun 24;350:h3337. doi: 10.1136/bmj.h3337. No abstract available.

PMID:
26108537
5.

Complications associated with oral anticoagulation therapy.

Howard PK.

Adv Emerg Nurs J. 2013 Oct-Dec;35(4):283-6. doi: 10.1097/TME.0b013e3182a9e9a2.

PMID:
24176826
6.

[New oral anticoagulants and digestive hemorrhages].

Diallo I, Mallaret C, Jourdan S, Brardjanian S, Guisset M, Coton T.

Presse Med. 2014 Jan;43(1):85-7. doi: 10.1016/j.lpm.2013.01.063. Epub 2013 May 21. French. No abstract available.

PMID:
23706679
7.

Anticoagulation, novel agents, and procedures: can we pardon the interruption?

Garcia DA, Granger CB.

Circulation. 2012 Jul 17;126(3):255-7. doi: 10.1161/CIRCULATIONAHA.112.115188. Epub 2012 Jun 14. No abstract available.

8.

Dabigatran for stroke prevention in all patients with atrial fibrillation?

Hunchuck JE, Lake JD.

Pharmacotherapy. 2011 Aug;31(8):725-8. doi: 10.1592/phco.31.8.725. No abstract available.

PMID:
21923597
9.

Dabigatran-induced upper intestinal bleeding in a patient with chronic kidney disease.

Ribés-Cruz JJ, Torregrosa-Maicas I, Ramos-Tomás C, Solís-Salguero MA, Puchades-Montesa MJ, González-Rico MA, Juan-García I, Tomás-Simó P, Tejedor-Alonso S, Zambrano-Esteves P, Miguel-Carrasco A.

Nefrologia. 2013 Nov 13;33(6):864-6. doi: 10.3265/Nefrologia.pre2013.Jul.12040. English, Spanish. No abstract available.

10.

Dabigatran and mechanical valves: less effective and more risky than warfarin.

[No authors listed]

Prescrire Int. 2013 May;22(138):128. No abstract available.

PMID:
23819180
11.

Response to letters regarding article, “Periprocedural bleeding and thromboembolic events with dabigatran compared with warfarin: results from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Randomized Trial”.

Healey JS, Eikelboom J, Yang S, Themeles E, Connolly SJ, Yusuf S, Douketis J, Wallentin L, Oldgren J, Heidbuchel H, Avezum A, Reilly P, Ezekowitz M.

Circulation. 2013 Mar 19;127(11):e506. No abstract available.

14.

Periprocedural bleeding and thromboembolic events with dabigatran compared with warfarin: results from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) randomized trial.

Healey JS, Eikelboom J, Douketis J, Wallentin L, Oldgren J, Yang S, Themeles E, Heidbuchel H, Avezum A, Reilly P, Connolly SJ, Yusuf S, Ezekowitz M; RE-LY Investigators..

Circulation. 2012 Jul 17;126(3):343-8. doi: 10.1161/CIRCULATIONAHA.111.090464. Epub 2012 Jun 14. Erratum in: Circulation. 2012 Sep 4;126(10):e160. Heidbuchle, Hein [corrected to Heidbuchel, Hein].

15.

Dabigatran versus warfarin in patients with atrial fibrillation: an analysis of patients undergoing cardioversion.

Nagarakanti R, Ezekowitz MD, Oldgren J, Yang S, Chernick M, Aikens TH, Flaker G, Brugada J, Kamensky G, Parekh A, Reilly PA, Yusuf S, Connolly SJ.

Circulation. 2011 Jan 18;123(2):131-6. doi: 10.1161/CIRCULATIONAHA.110.977546. Epub 2011 Jan 3.

16.

Dabigatran: uncharted waters and potential harms.

Radecki RP.

Ann Intern Med. 2012 Jul 3;157(1):66-8. doi: 10.7326/0003-4819-157-1-201207030-00467. No abstract available. Erratum in: Ann Intern Med. 2012 Sep 4;157(5):388.

PMID:
22751762
17.

Intracerebral hemorrhage: Pick your poison.

Michota F.

Cleve Clin J Med. 2010 Nov;77(11):743-6. doi: 10.3949/ccjm.77a.10103. Review. No abstract available.

18.

Complications of anticoagulation.

Bilen O, Teruya J.

Dis Mon. 2012 Aug;58(8):440-7. doi: 10.1016/j.disamonth.2012.04.002. Review. No abstract available.

PMID:
22818558
19.

Stroke prophylaxis with warfarin or dabigatran for patients with non-valvular atrial fibrillation-cost analysis.

Ali A, Bailey C, Abdelhafiz AH.

Age Ageing. 2012 Sep;41(5):681-4. doi: 10.1093/ageing/afs017. Epub 2012 Feb 28.

PMID:
22378612
20.

Anticoagulation with dabigatran does not increase secondary intracerebral haemorrhage after thrombolysis in experimental cerebral ischaemia.

Sun L, Zhou W, Ploen R, Zorn M, Veltkamp R.

Thromb Haemost. 2013 Jul;110(1):153-61. doi: 10.1160/TH12-12-0942. Epub 2013 Apr 25.

PMID:
23615682

Supplemental Content

Support Center